JPMorgan Chase & Co’s Surface Oncology, Inc. Common Stock SURF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,407
| Closed | -$1.22K | – | 6726 |
|
|
2023
Q2 | $1.22K | Hold |
1,407
| – | – | ﹤0.01% | 5523 |
|
|
2023
Q1 | $1K | Hold |
1,407
| – | – | ﹤0.01% | 5717 |
|
|
2022
Q4 | $1K | Sell |
1,407
-2,351
| -63% | -$1.67K | ﹤0.01% | 5521 |
|
|
2022
Q3 | $4K | Buy |
3,758
+2,423
| +181% | +$2.58K | ﹤0.01% | 5256 |
|
|
2022
Q2 | $2K | Sell |
1,335
-20,747
| -94% | -$31.1K | ﹤0.01% | 5451 |
|
|
2022
Q1 | $65K | Buy |
22,082
+4,611
| +26% | +$13.6K | ﹤0.01% | 4915 |
|
|
2021
Q4 | $84K | Buy |
17,471
+598
| +4% | +$2.88K | ﹤0.01% | 4895 |
|
|
2021
Q3 | $128K | Buy |
16,873
+1,673
| +11% | +$12.7K | ﹤0.01% | 4602 |
|
|
2021
Q2 | $113K | Buy |
15,200
+14,800
| +3,700% | +$110K | ﹤0.01% | 4729 |
|
|
2021
Q1 | $3K | Buy |
+400
| New | +$3K | ﹤0.01% | 5140 |
|
|
2020
Q4 | – | Sell |
-17,719
| Closed | -$115K | – | 5176 |
|
|
2020
Q3 | $115K | Buy |
17,719
+17,708
| +160,982% | +$115K | ﹤0.01% | 3988 |
|
|
2020
Q2 | $0 | Buy |
+11
| New | – | ﹤0.01% | 5029 |
|
|
2019
Q3 | – | Sell |
-5,054
| Closed | -$14K | – | 4959 |
|
|
2019
Q2 | $14K | Buy |
5,054
+2,296
| +83% | +$6.36K | ﹤0.01% | 4587 |
|
|
2019
Q1 | $13K | Sell |
2,758
-23,164
| -89% | -$109K | ﹤0.01% | 4596 |
|
|
2018
Q4 | $110K | Buy |
25,922
+24,239
| +1,440% | +$103K | ﹤0.01% | 4011 |
|
|
2018
Q3 | $18K | Buy |
1,683
+207
| +14% | +$2.21K | ﹤0.01% | 4588 |
|
|
2018
Q2 | $24K | Buy |
+1,476
| New | +$24K | ﹤0.01% | 4502 |
|